RORY WILDNER: Open Payments
NPI 1366960197 · KALAMAZOO, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$325 in 18 payments from 11 companies in 2025. Trend: 2023 $993 · 2024 $1,747 · 2025 $325
Food & beverage: $325
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $66 |
| Amgen Inc. | 3 | $52 |
| Axsome Therapeutics, Inc. | 2 | $48 |
| Lilly USA, LLC | 2 | $34 |
| Astellas Pharma US Inc | 1 | $21 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $21 |
| Cranial Technologies, Inc | 1 | $20 |
| Phadia US Inc. | 1 | $17 |
| PFIZER INC. | 1 | $16 |
| Merck Sharp & Dohme LLC | 1 | $15 |
Products named: OTEZLA, Auvelity, Wegovy, MOUNJARO, Veozah, JARDIANCE, Doc Band, ImmunoCAP.
Industry payments across MI — which companies pay providers there.
